These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20878507)

  • 41. [Antidepressants in bipolar disorder].
    Courtet P; Samalin L; Olié E
    Encephale; 2011 Dec; 37 Suppl 3():S196-202. PubMed ID: 22212875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bipolar depression: issues in diagnosis and treatment.
    Thase ME
    Harv Rev Psychiatry; 2005; 13(5):257-71. PubMed ID: 16251165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antidepressants in bipolar depression: yes, no, maybe?
    Malhi GS
    Evid Based Ment Health; 2015 Nov; 18(4):100-2. PubMed ID: 26459471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Making optimal use of combination pharmacotherapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2004; 65 Suppl 15():21-4. PubMed ID: 15554792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants.
    Fornaro M; Anastasia A; Monaco F; Novello S; Fusco A; Iasevoli F; De Berardis D; Veronese N; Solmi M; de Bartolomeis A
    J Affect Disord; 2018 Jul; 234():131-138. PubMed ID: 29525354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology.
    Born C; Seitz NN; Grunze H; Vieta E; Dittmann S; Seemüller F; Amann B
    Acta Psychiatr Scand; 2009 Dec; 120(6):474-80. PubMed ID: 19485960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
    Yatham LN; Arumugham SS; Kesavan M; Ramachandran K; Murthy NS; Saraf G; Ouyang Y; Bond DJ; Schaffer A; Ravindran A; Ravindran N; Frey BN; Daigneault A; Beaulieu S; Lam RW; Kondapuram N; Reddy MS; Bhandary RP; Ashok MV; Ha K; Ahn YM; Milev R; Wong H; Reddy YCJ;
    N Engl J Med; 2023 Aug; 389(5):430-440. PubMed ID: 37530824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spotlight on lamotrigine in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
    BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR; Elhaj O; Gajwani P; Gao K
    J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Expert Consensus Guidelines for treating depression in bipolar disorder.
    Frances AJ; Kahn DA; Carpenter D; Docherty JP; Donovan SL
    J Clin Psychiatry; 1998; 59 Suppl 4():73-9. PubMed ID: 9554324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD; Luo L; Shults J
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bipolar depression: management options.
    Malhi GS; Mitchell PB; Salim S
    CNS Drugs; 2003; 17(1):9-25. PubMed ID: 12467490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The precipitants of manic/hypomanic episodes in the context of bipolar disorder: a review.
    Proudfoot J; Doran J; Manicavasagar V; Parker G
    J Affect Disord; 2011 Oct; 133(3):381-7. PubMed ID: 21106249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.
    Kusumakar V
    J Clin Psychiatry; 2002; 63 Suppl 10():23-8. PubMed ID: 12392350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.